Paul P. Carbone

from Wikipedia, the free encyclopedia

Paul Peter Carbone (born May 2, 1931 in White Plains , New York , † February 22, 2002 in Singapore ) was an American oncologist .

Carbone attended Union College in Schenectady and studied medicine at Albany Medical College . From 1972 to 1976 he was Associate Director for Medical Oncology at the National Cancer Institute in Bethesda and from 1976 Professor at the University of Wisconsin – Madison , whose Comprehensive Cancer Center he directed from 1978 to 1997 (it was named after him in 2006). In 1987 he retired as professor.

In 1972 he received the Lasker ~ DeBakey Clinical Medical Research Award for his contributions to a combination chemotherapy of Hodgkin's lymphoma with the MOPP preparation. The M stands for Mustargen ( mechlorethamine ), the O for Oncovin ( vincristine ) and the two P for procarbazine and prednisone . It was developed at the National Cancer Institute in the 1960s under Vincent T. DeVita . This enabled a five-year survival rate of 70 percent to be achieved in Hodgkin's lymphoma.

He also received the American Cancer Society's Medal of Honor for Clinical Research . He was President of the American Society of Clinical Oncology (ASCO) and President of the American Association for Cancer Research in 1972/73 . In 1971 he founded the Eastern Cooperative Oncology Group . He also had close ties to Italian oncologists such as Umberto Veronesi and advised on the establishment of cancer research centers around the world. He died of a heart attack on one such trip to Singapore.

Web links

Individual evidence

  1. ^ Lasker Award 1972